Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 4/2008

01.07.2008 | Original Article

Cigarette smoke-induced pancreatic damage—experimental data

verfasst von: Uwe A. Wittel, Ulrich T. Hopt, Surinder K. Batra

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Abstract

Background and aims

Epidemiological data clearly indicate that cigarette smoking is associated with an increased risk for developing chronic pancreatitis and pancreatic cancer. Despite of this clear epidemiological correlation, cigarette smoke-induced pancreatic damage has only been investigated in a small number of experimental studies.

Methods

Experimental studies examining the effect of cigarette smoke or cigarette smoke constituents on the pancreas were reviewed.

Results

Recent data indicate that smoking also induces chronic pancreatic inflammation in rodents within a period of 12 weeks upon exposure with environmental cigarette smoke. Supported by the finding that morphologic pancreatic damage is also induced by nicotine treatment, cigarette smoke-induced pancreatic damage is likely to be caused by a disturbance of regulation of exocrine pancreas. The morphological alterations, however, induced by nicotine, are less pronounced and therefore, other substances and pathophysiologic mechanisms, such as carcinogen action or cigarette smoke-induced reduction of anti-protease activity, are likely to aggravate pancreatic damage upon cigarette smoke inhalation.

Conclusion

These data indicate that several constituents of cigarette smoke induce a disturbance of pancreatic function. This multifactorial event induces morphologic pancreatic damage upon cigarette smoke exposure in rodents.
Literatur
1.
Zurück zum Zitat Weiss W, Benarde MA (1983) The temporal relation between cigarette smoking and pancreatic cancer. Am J Public Health 73:1403–1404PubMed Weiss W, Benarde MA (1983) The temporal relation between cigarette smoking and pancreatic cancer. Am J Public Health 73:1403–1404PubMed
2.
Zurück zum Zitat Levi F, Lucchini F, Negri E, La VC (2003) Pancreatic cancer mortality in Europe: the leveling of an epidemic. Pancreas 27:139–142PubMedCrossRef Levi F, Lucchini F, Negri E, La VC (2003) Pancreatic cancer mortality in Europe: the leveling of an epidemic. Pancreas 27:139–142PubMedCrossRef
3.
Zurück zum Zitat Parkin DM, Pisani P, Lopez AD, Masuyer E (1994) At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer 59:494–504PubMedCrossRef Parkin DM, Pisani P, Lopez AD, Masuyer E (1994) At least one in seven cases of cancer is caused by smoking. Global estimates for 1985. Int J Cancer 59:494–504PubMedCrossRef
4.
Zurück zum Zitat Fernandez E, La VC, Porta M, Negri E, Lucchini F, Levi F (1994) Trends in pancreatic cancer mortality in Europe, 1955–1989. Int J Cancer 57:786–792PubMedCrossRef Fernandez E, La VC, Porta M, Negri E, Lucchini F, Levi F (1994) Trends in pancreatic cancer mortality in Europe, 1955–1989. Int J Cancer 57:786–792PubMedCrossRef
5.
Zurück zum Zitat Mulder I, Hoogenveen RT, van Genugten ML, Lankisch PG, Lowenfels AB, de Hollander AE, Bueno-de-Mesquita HB (2002) Smoking cessation would substantially reduce the future incidence of pancreatic cancer in the European Union. Eur J Gastroenterol Hepatol 14:1343–1353PubMedCrossRef Mulder I, Hoogenveen RT, van Genugten ML, Lankisch PG, Lowenfels AB, de Hollander AE, Bueno-de-Mesquita HB (2002) Smoking cessation would substantially reduce the future incidence of pancreatic cancer in the European Union. Eur J Gastroenterol Hepatol 14:1343–1353PubMedCrossRef
6.
Zurück zum Zitat Prokopczyk B, Hoffmann D, Bologna M, Cunningham AJ, Trushin N, Akerkar S, Boyiri T, Amin S, Desai D, Colosimo S, Pittman B, Leder G, Ramadani M, Henne-Bruns D, Beger HG, El-Bayoumy K (2002) Identification of tobacco-derived compounds in human pancreatic juice. Chem Res Toxicol 15:677–685PubMedCrossRef Prokopczyk B, Hoffmann D, Bologna M, Cunningham AJ, Trushin N, Akerkar S, Boyiri T, Amin S, Desai D, Colosimo S, Pittman B, Leder G, Ramadani M, Henne-Bruns D, Beger HG, El-Bayoumy K (2002) Identification of tobacco-derived compounds in human pancreatic juice. Chem Res Toxicol 15:677–685PubMedCrossRef
7.
Zurück zum Zitat IARC (2004) Tobacco smoke and involuntary smoking. IARC monographs on the evaluation of carcinogenic risks to humans, vol 83. WHO International Agency for Research on Cancer, Lyon, France IARC (2004) Tobacco smoke and involuntary smoking. IARC monographs on the evaluation of carcinogenic risks to humans, vol 83. WHO International Agency for Research on Cancer, Lyon, France
8.
Zurück zum Zitat Rao MS (1987) Animal models of exocrine pancreatic carcinogenesis. Cancer Metastasis Rev 6:665–676PubMedCrossRef Rao MS (1987) Animal models of exocrine pancreatic carcinogenesis. Cancer Metastasis Rev 6:665–676PubMedCrossRef
9.
Zurück zum Zitat Wei D, Xiong HQ, Abbruzzese JL, Xie K (2003) Experimental animal models of pancreatic carcinogenesis and metastasis. Int J Gastrointest Cancer 33:43–60PubMedCrossRef Wei D, Xiong HQ, Abbruzzese JL, Xie K (2003) Experimental animal models of pancreatic carcinogenesis and metastasis. Int J Gastrointest Cancer 33:43–60PubMedCrossRef
10.
Zurück zum Zitat Chowdhury P, MacLeod S, Udupa KB, Rayford PL (2002) Pathophysiological effects of nicotine on the pancreas: an update. Exp Biol Med (Maywood) 227:445–454 Chowdhury P, MacLeod S, Udupa KB, Rayford PL (2002) Pathophysiological effects of nicotine on the pancreas: an update. Exp Biol Med (Maywood) 227:445–454
11.
Zurück zum Zitat Schuller HM (2007) Neurotransmitter receptor-mediated signaling pathways as modulators of carcinogenesis. Prog Exp Tumor Res 39:45–63PubMedCrossRef Schuller HM (2007) Neurotransmitter receptor-mediated signaling pathways as modulators of carcinogenesis. Prog Exp Tumor Res 39:45–63PubMedCrossRef
12.
Zurück zum Zitat Hoffmann D, Rivenson A, Abbi R, Wynder EL (1993) A study of tobacco carcinogenesis: effect of the fat content of the diet on the carcinogenic activity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats. Cancer Res 53:2758–2761PubMed Hoffmann D, Rivenson A, Abbi R, Wynder EL (1993) A study of tobacco carcinogenesis: effect of the fat content of the diet on the carcinogenic activity of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in F344 rats. Cancer Res 53:2758–2761PubMed
13.
Zurück zum Zitat Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht SS (1988) Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res 48:6912–6917PubMed Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht SS (1988) Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res 48:6912–6917PubMed
14.
Zurück zum Zitat Standop J, Schneider MB, Ulrich A, Pour PM (2001) Experimental animal models in pancreatic carcinogenesis: lessons for human pancreatic cancer. Dig Dis 19:24–31PubMedCrossRef Standop J, Schneider MB, Ulrich A, Pour PM (2001) Experimental animal models in pancreatic carcinogenesis: lessons for human pancreatic cancer. Dig Dis 19:24–31PubMedCrossRef
15.
Zurück zum Zitat Bockman DE, Guo J, Buchler P, Muller MW, Bergmann F, Friess H (2003) Origin and development of the precursor lesions in experimental pancreatic cancer in rats. Lab Invest 83:853–859PubMed Bockman DE, Guo J, Buchler P, Muller MW, Bergmann F, Friess H (2003) Origin and development of the precursor lesions in experimental pancreatic cancer in rats. Lab Invest 83:853–859PubMed
16.
Zurück zum Zitat Chowdhury P, Doi R, Tangoku A, Rayford PL (1995) Structural and functional changes of rat exocrine pancreas exposed to nicotine. Int J Pancreatol 18:257–264PubMed Chowdhury P, Doi R, Tangoku A, Rayford PL (1995) Structural and functional changes of rat exocrine pancreas exposed to nicotine. Int J Pancreatol 18:257–264PubMed
17.
Zurück zum Zitat van Westerloo DJ, Giebelen IA, Florquin S, Bruno MJ, Larosa GJ, Ulloa L, Tracey KJ, van der PT (2006) The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 130:1822–1830PubMedCrossRef van Westerloo DJ, Giebelen IA, Florquin S, Bruno MJ, Larosa GJ, Ulloa L, Tracey KJ, van der PT (2006) The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 130:1822–1830PubMedCrossRef
18.
Zurück zum Zitat Chowdhury P, Hosotani R, Rayford PL (1989) Inhibition of CCK or carbachol-stimulated amylase release by nicotine. Life Sci 45:2163–2168PubMedCrossRef Chowdhury P, Hosotani R, Rayford PL (1989) Inhibition of CCK or carbachol-stimulated amylase release by nicotine. Life Sci 45:2163–2168PubMedCrossRef
19.
Zurück zum Zitat Chowdhury P, Rayford PL, Chang LW (1992) Induction of pancreatic acinar pathology via inhalation of nicotine. Proc Soc Exp Biol Med 201:159–164PubMed Chowdhury P, Rayford PL, Chang LW (1992) Induction of pancreatic acinar pathology via inhalation of nicotine. Proc Soc Exp Biol Med 201:159–164PubMed
20.
Zurück zum Zitat Chowdhury P, Hosotani R, Chang L, Rayford PL (1990) Metabolic and pathologic effects of nicotine on gastrointestinal tract and pancreas of rats. Pancreas 5:222–229PubMedCrossRef Chowdhury P, Hosotani R, Chang L, Rayford PL (1990) Metabolic and pathologic effects of nicotine on gastrointestinal tract and pancreas of rats. Pancreas 5:222–229PubMedCrossRef
21.
Zurück zum Zitat Wittel UA, Singh AP, Henley BJ, Andrianifahanana M, Akhter MP, Cullen DM, Batra SK (2006) Cigarette smoke-induced differential expression of the genes involved in exocrine function of the rat pancreas. Pancreas 33:364–370PubMedCrossRef Wittel UA, Singh AP, Henley BJ, Andrianifahanana M, Akhter MP, Cullen DM, Batra SK (2006) Cigarette smoke-induced differential expression of the genes involved in exocrine function of the rat pancreas. Pancreas 33:364–370PubMedCrossRef
22.
Zurück zum Zitat Wittel UA, Pandey KK, Andrianifahanana M, Johansson SL, Cullen DM, Akhter MP, Brand RE, Prokopczyk B, Batra SK (2006) Chronic pancreatic inflammation induced by environmental tobacco smoke inhalation in rats. Am J Gastroenterol 101:148–159PubMedCrossRef Wittel UA, Pandey KK, Andrianifahanana M, Johansson SL, Cullen DM, Akhter MP, Brand RE, Prokopczyk B, Batra SK (2006) Chronic pancreatic inflammation induced by environmental tobacco smoke inhalation in rats. Am J Gastroenterol 101:148–159PubMedCrossRef
23.
Zurück zum Zitat Shi MM, Chong IW, Long NC, Love JA, Godleski JJ, Paulauskis JD (1998) Functional characterization of recombinant rat macrophage inflammatory protein-1 alpha and mRNA expression in pulmonary inflammation. Inflammation 22:29–43PubMedCrossRef Shi MM, Chong IW, Long NC, Love JA, Godleski JJ, Paulauskis JD (1998) Functional characterization of recombinant rat macrophage inflammatory protein-1 alpha and mRNA expression in pulmonary inflammation. Inflammation 22:29–43PubMedCrossRef
24.
Zurück zum Zitat Rau B, Paszkowski A, Lillich S, Baumgart K, Moller P, Beger HG (2001) Differential effects of caspase-1/interleukin-1beta-converting enzyme on acinar cell necrosis and apoptosis in severe acute experimental pancreatitis. Lab Invest 81:1001–1013PubMed Rau B, Paszkowski A, Lillich S, Baumgart K, Moller P, Beger HG (2001) Differential effects of caspase-1/interleukin-1beta-converting enzyme on acinar cell necrosis and apoptosis in severe acute experimental pancreatitis. Lab Invest 81:1001–1013PubMed
25.
Zurück zum Zitat Rane SG, Lee JH, Lin HM (2006) Transforming growth factor-beta pathway: role in pancreas development and pancreatic disease. Cytokine Growth Factor Rev 17:107–119PubMedCrossRef Rane SG, Lee JH, Lin HM (2006) Transforming growth factor-beta pathway: role in pancreas development and pancreatic disease. Cytokine Growth Factor Rev 17:107–119PubMedCrossRef
26.
Zurück zum Zitat Closa D, Motoo Y, Iovanna JL (2007) Pancreatitis-associated protein: from a lectin to an anti-inflammatory cytokine. World J Gastroenterol 13:170–174PubMed Closa D, Motoo Y, Iovanna JL (2007) Pancreatitis-associated protein: from a lectin to an anti-inflammatory cytokine. World J Gastroenterol 13:170–174PubMed
27.
Zurück zum Zitat Schiesser M, Bimmler D, Frick TW, Graf R (2001) Conformational changes of pancreatitis-associated protein (PAP) activated by trypsin lead to insoluble protein aggregates. Pancreas 22:186–192PubMedCrossRef Schiesser M, Bimmler D, Frick TW, Graf R (2001) Conformational changes of pancreatitis-associated protein (PAP) activated by trypsin lead to insoluble protein aggregates. Pancreas 22:186–192PubMedCrossRef
28.
Zurück zum Zitat Carter KJ, Rutledge PL, Steer ML, Silen W (1987) Secretagogue-induced changes in intracellular pH and amylase release in mouse pancreatic acini. Am J Physiol 253:G690–G696PubMed Carter KJ, Rutledge PL, Steer ML, Silen W (1987) Secretagogue-induced changes in intracellular pH and amylase release in mouse pancreatic acini. Am J Physiol 253:G690–G696PubMed
29.
Zurück zum Zitat Rosendahl J, Bodeker H, Mossner J, Teich N (2007) Hereditary chronic pancreatitis. Orphanet J Rare Dis 2:1PubMedCrossRef Rosendahl J, Bodeker H, Mossner J, Teich N (2007) Hereditary chronic pancreatitis. Orphanet J Rare Dis 2:1PubMedCrossRef
30.
Zurück zum Zitat Sahin-Toth M (2006) Biochemical models of hereditary pancreatitis. Endocrinol Metab Clin North Am 35:303–312PubMedCrossRef Sahin-Toth M (2006) Biochemical models of hereditary pancreatitis. Endocrinol Metab Clin North Am 35:303–312PubMedCrossRef
31.
Zurück zum Zitat Teich N, Rosendahl J, Toth M, Mossner J, Sahin-Toth M (2006) Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis. Hum Mutat 27:721–730PubMedCrossRef Teich N, Rosendahl J, Toth M, Mossner J, Sahin-Toth M (2006) Mutations of human cationic trypsinogen (PRSS1) and chronic pancreatitis. Hum Mutat 27:721–730PubMedCrossRef
32.
Zurück zum Zitat Archer H, Jura N, Keller J, Jacobson M, Bar-Sagi D (2006) A mouse model of hereditary pancreatitis generated by transgenic expression of R122H trypsinogen. Gastroenterology 131:1844–1855PubMedCrossRef Archer H, Jura N, Keller J, Jacobson M, Bar-Sagi D (2006) A mouse model of hereditary pancreatitis generated by transgenic expression of R122H trypsinogen. Gastroenterology 131:1844–1855PubMedCrossRef
33.
Zurück zum Zitat Simon P, Weiss FU, Sahin-Toth M, Parry M, Nayler O, Lenfers B, Schnekenburger J, Mayerle J, Domschke W, Lerch MM (2002) Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122→Cys) that alters autoactivation and autodegradation of cationic trypsinogen. J Biol Chem 277:5404–5410PubMedCrossRef Simon P, Weiss FU, Sahin-Toth M, Parry M, Nayler O, Lenfers B, Schnekenburger J, Mayerle J, Domschke W, Lerch MM (2002) Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122→Cys) that alters autoactivation and autodegradation of cationic trypsinogen. J Biol Chem 277:5404–5410PubMedCrossRef
34.
Zurück zum Zitat Witt H, Luck W, Hennies HC, Classen M, Kage A, Lass U, Landt O, Becker M (2000) Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 25:213–216PubMedCrossRef Witt H, Luck W, Hennies HC, Classen M, Kage A, Lass U, Landt O, Becker M (2000) Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 25:213–216PubMedCrossRef
35.
Zurück zum Zitat Kuwata K, Hirota M, Shimizu H, Nakae M, Nishihara S, Takimoto A, Mitsushima K, Kikuchi N, Endo K, Inoue M, Ogawa M (2002) Functional analysis of recombinant pancreatic secretory trypsin inhibitor protein with amino-acid substitution. J Gastroenterol 37:928–934PubMedCrossRef Kuwata K, Hirota M, Shimizu H, Nakae M, Nishihara S, Takimoto A, Mitsushima K, Kikuchi N, Endo K, Inoue M, Ogawa M (2002) Functional analysis of recombinant pancreatic secretory trypsin inhibitor protein with amino-acid substitution. J Gastroenterol 37:928–934PubMedCrossRef
36.
Zurück zum Zitat Kiraly O, Boulling A, Witt H, Le MC, Chen JM, Rosendahl J, Battaggia C, Wartmann T, Sahin-Toth M, Ferec C (2007) Signal peptide variants that impair secretion of pancreatic secretory trypsin inhibitor (SPINK1) cause autosomal dominant hereditary pancreatitis. Hum Mutat 28:469–476PubMedCrossRef Kiraly O, Boulling A, Witt H, Le MC, Chen JM, Rosendahl J, Battaggia C, Wartmann T, Sahin-Toth M, Ferec C (2007) Signal peptide variants that impair secretion of pancreatic secretory trypsin inhibitor (SPINK1) cause autosomal dominant hereditary pancreatitis. Hum Mutat 28:469–476PubMedCrossRef
37.
Zurück zum Zitat Boulling A, Le MC, Trouve P, Raguenes O, Chen JM, Ferec C (2007) Functional analysis of pancreatitis-associated missense mutations in the pancreatic secretory trypsin inhibitor (SPINK1) gene. Eur J Hum Genet 15:936–942PubMedCrossRef Boulling A, Le MC, Trouve P, Raguenes O, Chen JM, Ferec C (2007) Functional analysis of pancreatitis-associated missense mutations in the pancreatic secretory trypsin inhibitor (SPINK1) gene. Eur J Hum Genet 15:936–942PubMedCrossRef
38.
Zurück zum Zitat Kiraly O, Wartmann T, Sahin-Toth M (2007) Missense mutations in pancreatic secretory trypsin inhibitor (SPINK1) cause intracellular retention and degradation. Gut 56:1434–1439CrossRef Kiraly O, Wartmann T, Sahin-Toth M (2007) Missense mutations in pancreatic secretory trypsin inhibitor (SPINK1) cause intracellular retention and degradation. Gut 56:1434–1439CrossRef
39.
Zurück zum Zitat Masamune A, Kume K, Takagi Y, Kikuta K, Satoh K, Satoh A, Shimosegawa T (2007) N34S mutation in the SPINK1 gene is not associated with alternative splicing. Pancreas 34:423–428PubMedCrossRef Masamune A, Kume K, Takagi Y, Kikuta K, Satoh K, Satoh A, Shimosegawa T (2007) N34S mutation in the SPINK1 gene is not associated with alternative splicing. Pancreas 34:423–428PubMedCrossRef
40.
Zurück zum Zitat Witt H, Sahin-Toth M, Landt O, Chen JM, Kahne T, Drenth JP, Kukor Z, Szepessy E, Halangk W, Dahm S, Rohde K, Schulz HU, Le MC, Akar N, Ammann RW, Truninger K, Bargetzi M, Bhatia E, Castellani C, Cavestro GM, Cerny M, stro-Bisol G, Spedini G, Eiberg H, Jansen JB, Koudova M, Rausova E, Macek M Jr., Malats N, Real FX, Menzel HJ, Moral P, Galavotti R, Pignatti PF, Rickards O, Spicak J, Zarnescu NO, Bock W, Gress TM, Friess H, Ockenga J, Schmidt H, Pfutzer R, Lohr M, Simon P, Weiss FU, Lerch MM, Teich N, Keim V, Berg T, Wiedenmann B, Luck W, Groneberg DA, Becker M, Keil T, Kage A, Bernardova J, Braun M, Guldner C, Halangk J, Rosendahl J, Witt U, Treiber M, Nickel R, Ferec C (2006) A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nat Genet 38:668–673PubMedCrossRef Witt H, Sahin-Toth M, Landt O, Chen JM, Kahne T, Drenth JP, Kukor Z, Szepessy E, Halangk W, Dahm S, Rohde K, Schulz HU, Le MC, Akar N, Ammann RW, Truninger K, Bargetzi M, Bhatia E, Castellani C, Cavestro GM, Cerny M, stro-Bisol G, Spedini G, Eiberg H, Jansen JB, Koudova M, Rausova E, Macek M Jr., Malats N, Real FX, Menzel HJ, Moral P, Galavotti R, Pignatti PF, Rickards O, Spicak J, Zarnescu NO, Bock W, Gress TM, Friess H, Ockenga J, Schmidt H, Pfutzer R, Lohr M, Simon P, Weiss FU, Lerch MM, Teich N, Keim V, Berg T, Wiedenmann B, Luck W, Groneberg DA, Becker M, Keil T, Kage A, Bernardova J, Braun M, Guldner C, Halangk J, Rosendahl J, Witt U, Treiber M, Nickel R, Ferec C (2006) A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nat Genet 38:668–673PubMedCrossRef
41.
Zurück zum Zitat Morosco GJ, Goeringer GC (1979) Pancreatic elastase and serum alpha 1-antitrypsin levels in beagle dogs smoking high- and low-nicotine cigarettes: possible mechanism of pancreatic cancer in cigarette smokers. J Toxicol Environ Health 5:879–890PubMedCrossRef Morosco GJ, Goeringer GC (1979) Pancreatic elastase and serum alpha 1-antitrypsin levels in beagle dogs smoking high- and low-nicotine cigarettes: possible mechanism of pancreatic cancer in cigarette smokers. J Toxicol Environ Health 5:879–890PubMedCrossRef
42.
Zurück zum Zitat Janoff A, Carp H, Lee DK, Drew RT (1979) Cigarette smoke inhalation decreases alpha 1-antitrypsin activity in rat lung. Science 206:1313–1314PubMedCrossRef Janoff A, Carp H, Lee DK, Drew RT (1979) Cigarette smoke inhalation decreases alpha 1-antitrypsin activity in rat lung. Science 206:1313–1314PubMedCrossRef
43.
Zurück zum Zitat Evans MD, Church DF, Pryor WA (1991) Aqueous cigarette tar extracts damage human alpha-1-proteinase inhibitor. Chem Biol Interact 79:151–164PubMedCrossRef Evans MD, Church DF, Pryor WA (1991) Aqueous cigarette tar extracts damage human alpha-1-proteinase inhibitor. Chem Biol Interact 79:151–164PubMedCrossRef
44.
Zurück zum Zitat Aubertin A (1991) Vitamin C: how it may protect against cancer is unclear. J Natl Cancer Inst 83:396–397PubMedCrossRef Aubertin A (1991) Vitamin C: how it may protect against cancer is unclear. J Natl Cancer Inst 83:396–397PubMedCrossRef
45.
Zurück zum Zitat Pryor WA, Dooley MM, Church DF (1986) The inactivation of alpha-1-proteinase inhibitor by gas-phase cigarette smoke: protection by antioxidants and reducing species. Chem Biol Interact 57:271–283PubMedCrossRef Pryor WA, Dooley MM, Church DF (1986) The inactivation of alpha-1-proteinase inhibitor by gas-phase cigarette smoke: protection by antioxidants and reducing species. Chem Biol Interact 57:271–283PubMedCrossRef
46.
Zurück zum Zitat Stockley RA, Afford SC (1983) The interaction of cigarette smoke solution with alpha 1-antitrypsin: effect on inhibitory capacity, electrophoretic mobility and immunological measurement. Clin Sci (Lond) 64:223–230 Stockley RA, Afford SC (1983) The interaction of cigarette smoke solution with alpha 1-antitrypsin: effect on inhibitory capacity, electrophoretic mobility and immunological measurement. Clin Sci (Lond) 64:223–230
47.
Zurück zum Zitat Janoff A, Dearing R (1982) Alpha 1-proteinase inhibitor is more sensitive to inactivation by cigarette smoke than is leukocyte elastase. Am Rev Respir Dis 126:691–694PubMed Janoff A, Dearing R (1982) Alpha 1-proteinase inhibitor is more sensitive to inactivation by cigarette smoke than is leukocyte elastase. Am Rev Respir Dis 126:691–694PubMed
48.
Zurück zum Zitat Chowdhury P, Bone RC, Louria DB, Rayford PL (1982) Effect of cigarette smoke on human serum trypsin inhibitory capacity and antitrypsin concentration. Am Rev Respir Dis 126:177–179PubMed Chowdhury P, Bone RC, Louria DB, Rayford PL (1982) Effect of cigarette smoke on human serum trypsin inhibitory capacity and antitrypsin concentration. Am Rev Respir Dis 126:177–179PubMed
49.
Zurück zum Zitat Ito H, Watanabe T, Shore SR, Aviado DM (1976) Functional and biochemical effects on the lung following inhalation of cigarette smoke and its constituents. III. Serum antitrypsin and bronchomotor responses in rats. Toxicol Appl Pharmacol 35:403–412PubMedCrossRef Ito H, Watanabe T, Shore SR, Aviado DM (1976) Functional and biochemical effects on the lung following inhalation of cigarette smoke and its constituents. III. Serum antitrypsin and bronchomotor responses in rats. Toxicol Appl Pharmacol 35:403–412PubMedCrossRef
50.
Zurück zum Zitat Majumdar AP, Davis GA, Dubick MA, Geokas MC (1985) Nicotine stimulation of protein secretion from isolated rat pancreatic acini. Am J Physiol 248:G158–G163PubMed Majumdar AP, Davis GA, Dubick MA, Geokas MC (1985) Nicotine stimulation of protein secretion from isolated rat pancreatic acini. Am J Physiol 248:G158–G163PubMed
51.
Zurück zum Zitat Baskaran K, Laconi S, Reddy MK (1994) Transformation of hamster pancreatic duct cells by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in vitro. Carcinogenesis 15:2461–2466PubMedCrossRef Baskaran K, Laconi S, Reddy MK (1994) Transformation of hamster pancreatic duct cells by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in vitro. Carcinogenesis 15:2461–2466PubMedCrossRef
52.
Zurück zum Zitat Ho YS, Chen CH, Wang YJ, Pestell RG, Albanese C, Chen RJ, Chang MC, Jeng JH, Lin SY, Liang YC, Tseng H, Lee WS, Lin JK, Chu JS, Chen LC, Lee CH, Tso WL, Lai YC, Wu CH (2005) Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces cell proliferation in normal human bronchial epithelial cells through NFkappaB activation and cyclin D1 up-regulation. Toxicol Appl Pharmacol 205:133–148PubMedCrossRef Ho YS, Chen CH, Wang YJ, Pestell RG, Albanese C, Chen RJ, Chang MC, Jeng JH, Lin SY, Liang YC, Tseng H, Lee WS, Lin JK, Chu JS, Chen LC, Lee CH, Tso WL, Lai YC, Wu CH (2005) Tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces cell proliferation in normal human bronchial epithelial cells through NFkappaB activation and cyclin D1 up-regulation. Toxicol Appl Pharmacol 205:133–148PubMedCrossRef
53.
Zurück zum Zitat Schuller HM, Zhang L, Weddle DL, Castonguay A, Walker K, Miller MS (2002) The cyclooxygenase inhibitor ibuprofen and the FLAP inhibitor MK886 inhibit pancreatic carcinogenesis induced in hamsters by transplacental exposure to ethanol and the tobacco carcinogen NNK. J Cancer Res Clin Oncol 128:525–532PubMedCrossRef Schuller HM, Zhang L, Weddle DL, Castonguay A, Walker K, Miller MS (2002) The cyclooxygenase inhibitor ibuprofen and the FLAP inhibitor MK886 inhibit pancreatic carcinogenesis induced in hamsters by transplacental exposure to ethanol and the tobacco carcinogen NNK. J Cancer Res Clin Oncol 128:525–532PubMedCrossRef
54.
55.
Zurück zum Zitat Cancela JM, Van CF, Galione A, Tepikin AV, Petersen OH (2002) Transformation of local Ca2+ spikes to global Ca2+ transients: the combinatorial roles of multiple Ca2+ releasing messengers. EMBO J 21:909–919PubMedCrossRef Cancela JM, Van CF, Galione A, Tepikin AV, Petersen OH (2002) Transformation of local Ca2+ spikes to global Ca2+ transients: the combinatorial roles of multiple Ca2+ releasing messengers. EMBO J 21:909–919PubMedCrossRef
56.
Zurück zum Zitat Bragado MJ, Garcia LJ, Montero A, San Roman JI, Calvo JJ, Lopez MA (1993) Nicotinic cholinergic influences in pancreatic secretion induced by intraduodenal alkaline and acid solutions in the rabbit. Gen Pharmacol 24:687–692PubMed Bragado MJ, Garcia LJ, Montero A, San Roman JI, Calvo JJ, Lopez MA (1993) Nicotinic cholinergic influences in pancreatic secretion induced by intraduodenal alkaline and acid solutions in the rabbit. Gen Pharmacol 24:687–692PubMed
57.
Zurück zum Zitat Prokopczyk B, Leder G, Trushin N, Cunningham AJ, Akerkar S, Pittman B, Ramadani M, Straeter J, Beger HG, Henne-Bruns D, El-Bayoumy K (2005) 4-Hydroxy-1-(3-pyridyl)-1-butanone, an indicator for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA damage, is not detected in human pancreatic tissue. Cancer Epidemiol Biomarkers Prev 14:540–541PubMedCrossRef Prokopczyk B, Leder G, Trushin N, Cunningham AJ, Akerkar S, Pittman B, Ramadani M, Straeter J, Beger HG, Henne-Bruns D, El-Bayoumy K (2005) 4-Hydroxy-1-(3-pyridyl)-1-butanone, an indicator for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA damage, is not detected in human pancreatic tissue. Cancer Epidemiol Biomarkers Prev 14:540–541PubMedCrossRef
58.
Zurück zum Zitat Murthy SN, Dinoso VP Jr., Clearfield HR, Chey WY (1977) Simultaneous measurement of basal pancreatic, gastric acid secretion, plasma gastrin, and secretin during smoking. Gastroenterology 73:758–761PubMed Murthy SN, Dinoso VP Jr., Clearfield HR, Chey WY (1977) Simultaneous measurement of basal pancreatic, gastric acid secretion, plasma gastrin, and secretin during smoking. Gastroenterology 73:758–761PubMed
59.
Zurück zum Zitat Brown P (1976) The influence of smoking on pancreatic function in man. Med J Aust 2:290–293PubMed Brown P (1976) The influence of smoking on pancreatic function in man. Med J Aust 2:290–293PubMed
60.
Zurück zum Zitat Bynum TE, Solomon TE, Johnson LR, Jacobson ED (1972) Inhibition of pancreatic secretion in man by cigarette smoking. Gut 13:361–365PubMedCrossRef Bynum TE, Solomon TE, Johnson LR, Jacobson ED (1972) Inhibition of pancreatic secretion in man by cigarette smoking. Gut 13:361–365PubMedCrossRef
61.
Zurück zum Zitat Askari MD, Tsao MS, Schuller HM (2005) The tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone stimulates proliferation of immortalized human pancreatic duct epithelia through beta-adrenergic transactivation of EGF receptors. J Cancer Res Clin Oncol 131:639–648PubMedCrossRef Askari MD, Tsao MS, Schuller HM (2005) The tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone stimulates proliferation of immortalized human pancreatic duct epithelia through beta-adrenergic transactivation of EGF receptors. J Cancer Res Clin Oncol 131:639–648PubMedCrossRef
62.
Zurück zum Zitat Tai MH, Upham BL, Olson LK, Tsao MS, Reed Jr DN, Trosko JE (2007) Cigarette smoke components inhibited intercellular communication and differentiation in human pancreatic ductal epithelial cells. Int J Cancer 120:1855–1862PubMedCrossRef Tai MH, Upham BL, Olson LK, Tsao MS, Reed Jr DN, Trosko JE (2007) Cigarette smoke components inhibited intercellular communication and differentiation in human pancreatic ductal epithelial cells. Int J Cancer 120:1855–1862PubMedCrossRef
Metadaten
Titel
Cigarette smoke-induced pancreatic damage—experimental data
verfasst von
Uwe A. Wittel
Ulrich T. Hopt
Surinder K. Batra
Publikationsdatum
01.07.2008
Verlag
Springer-Verlag
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 4/2008
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-007-0273-3

Weitere Artikel der Ausgabe 4/2008

Langenbeck's Archives of Surgery 4/2008 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.